A multicenter, randomized, double-blind, placebo-controlled, parallel group study on the safety and efficacy of istaroxime for pre-cardiogenic shock
19 May 2025 (09:10 - 09:20)
Organised by: 
Slides
About the speaker
Institute of Heart Diseases, Wroclaw (Poland)
6 More presentations in this session
Associate Professor J. Biegus (Wroclaw, PL)
Mrs I. Farissa (Semarang, ID)
Associate Professor K. Damman (Groningen, NL)
Access the full session
The Event
Heart Failure 2025
19 May 2025
09:10 CET
You may be interested in
Congress Presentation
